broadly neutralizing antibodies present new prospects counter highly antigenically diverse viruses
certain human pathogens avoid elimination immune system rapidly mutating surface protein sites targeted antibody responses consequently tend problematic vaccine development behavior described prominent subset viruses-the highly antigenically diverse viruses-which include hiv influenza hepatitis c viruses however viruses harbor highly conserved exposed sites usually associated function can targeted broadly neutralizing antibodies recently many antibodies known advances field enabled increasing numbers identified molecular characterizations antibodies importantly sites vulnerability recognize give hope discovery new vaccines drugs
